Document is current

Any future updates will be listed below

How biotech companies evolve intellectual property management capabilities: lessons from Cambridge Antibody Technology

Crossref DOI link: https://doi.org/10.1038/s41587-026-03119-y

Published Online: 2026-05-18

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark